| Financial Year |
March 31 2023 |
| Monetary Funds |
411,911,850.29 |
| Held-for-trading Financial Assets |
164,156,981.65 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,577,412,557.67 |
| Advances to Suppliers |
231,313,359.22 |
| Other Receivables |
107,244,128.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,426,435,984.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,191,782.14 |
| Total Current Assets |
3,976,200,259.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
82,655,176.18 |
| Investment Properties |
2,662,685.25 |
| Fixed Assetes |
876,104,834.35 |
| Under-construction Projects |
214,061,611.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,466,546.88 |
| R&D expenses |
1,654,478.70 |
| Goodwill |
71,902,285.15 |
| Long-Term Deferred and Prepaid Expenses |
26,131,673.77 |
| Deferred Income Tax Assets |
68,167,989.40 |
| Other Non-Current Assets |
64,601,110.89 |
| Sub-Total of Non-Current Assets |
1,670,333,291.11 |
| Total Assets |
5,646,533,551.05 |
| Short-Term Loans |
1,075,770,632.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
321,798,556.76 |
| Accounts Payable |
275,554,433.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,926,610.77 |
| Taxes Payable |
25,901,011.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
160,379,386.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,237,644.62 |
| Other Current Liabilities |
43,406,350.49 |
| Sub-Total of Current Liabilities |
2,290,747,276.99 |
| Long-term Loans |
57,111,603.08 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
93,409,076.58 |
| Deferred Income Tax Liabilities |
20,790,215.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
258,564,540.71 |
| Total Liabilities |
2,549,311,817.70 |
| Paid-In Capital(Or Share Stock) |
534,474,505.00 |
| Capital Surplus |
1,011,152,362.83 |
| Surplus Reserve |
199,518,438.03 |
| LESS:Treasury Stock |
71,862,351.95 |
| Undistributed Profits |
1,339,369,682.51 |
| Minority Stockholder's Interest |
43,795,967.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,053,425,766.15 |
| Owner's Equity（Stockholder's Equity） |
3,097,221,733.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,646,533,551.05 |
